Genomtec S.A. (WSE:GMT)
Poland flag Poland · Delayed Price · Currency is PLN
4.440
-0.120 (-2.63%)
Jul 21, 2026, 5:00 PM CET

Genomtec Cash Flow Statement

Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-2.57-10.22-11.21-9.01-11.93-7.12
Depreciation & Amortization
2.532.432.331.160.440.5
Stock-Based Compensation
1.521.52--4.830.21
Other Adjustments
0.140.580.08-0.040.260.04
Change in Receivables
-2.5-2.471.1-1.29-0.08-0.06
Changes in Inventories
---0.110.09-0.08
Changes in Accounts Payable
0.310.2-0.10.160.150.49
Changes in Accrued Expenses
-0.1-0.130.07-0.040.110.03
Changes in Other Operating Activities
-2.39-2.761.011.012.530.48
Operating Cash Flow
-9.34-10.86-6.72-7.95-3.6-5.5
Capital Expenditures
0.070.090.063.534.330.21
Sale of Property, Plant & Equipment
---0.11--
Purchases of Investments
-4.20.370.45--
Other Investing Activities
0.040.040.040.06--
Investing Cash Flow
-4.25-4.25-0.38-3.8-4.33-0.21
Long-Term Debt Issued
---0.510.320.3
Long-Term Debt Repaid
----0.5-10.14-0.25
Net Long-Term Debt Issued (Repaid)
---00.180.05
Issuance of Common Stock
-0.2510.5310.5112.4311.2-
Net Common Stock Issued (Repurchased)
-0.2510.5310.5112.4311.2-
Other Financing Activities
1.21.180.880.630.690.27
Financing Cash Flow
-1.459.359.6211.810.7-0.22
Effect of Exchange Rate Changes on Cash and Cash Equivalents
----0.01-0.010.02
Net Cash Flow
-15.01-5.752.530.042.77-5.94
Free Cash Flow
-9.28-10.77-6.66-4.430.74-5.29
FCF Margin
-184.10%-266.86%-286.82%-386.13%151.65%-2440.86%
Free Cash Flow Per Share
-0.61-0.71-0.49-0.350.07-0.60
Levered Free Cash Flow
-16.92-10.39-7.83-12.11-16.02-3.59
Unlevered Free Cash Flow
-8.27-9.67-7.7-3.21-3.9-5.33